Photocure $PHO.OL
PHO presented Q2 2019 numbers today, with most numbers landing very close to expectations.
Webcast: https://webtv.hegnar.no/presentation.php?webcastId=98041425
Press release: https://newsweb.oslobors.no/message/482310
Armchair Healthcare podcast interview with CEO Dan Schneider: https://twitter.com/MaxJacobsEdison/status/1151116879089586176
Webcast: https://webtv.hegnar.no/presentation.php?webcastId=98041425
Press release: https://newsweb.oslobors.no/message/482310
Armchair Healthcare podcast interview with CEO Dan Schneider: https://twitter.com/MaxJacobsEdison/status/1151116879089586176
交易進行
Trade very much active after two analyst BUY recommendations this week:Edison, target price NOK 69.
Norne securities, target price NOK 64.
At the current shareprice of NOK 53 this represents a reasonable upside potential.
交易進行
Trade still active, coming into a crucial phase where either a stop or new upwards movement can be triggered交易進行
With crucial Q3 presentation coming up, PHO still trades within clearly defined trading range.Nice update from company today:
photocure.com/news/siu2019_athens/
交易結束:目標達成
Safe choice is to end this trade today before Photocure Q3 presentation, as the stock has been known to make some drastic biotech sell the news moves.We can note a nice 49 to 59 NOK swing on this trade.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。